AI assistant
Inogen Inc — Director's Dealing 2014
Feb 13, 2014
33625_dirs_2014-02-12_9984c5be-0d28-4df4-b0e6-c8b2c74e7291.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Inogen Inc (INGN)
CIK: 0001294133
Period of Report: 2014-02-12
Reporting Person: Versant Ventures II LLC (10% Owner)
Reporting Person: Versant Venture Capital II, LP (10% Owner)
Reporting Person: Versant Side Fund II, LP (10% Owner)
Reporting Person: Versant Affiliates Fund II-A, LP (10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 911 | Indirect |
| Common Stock | 427 | Indirect |
| Common Stock | 48098 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Series B Preferred Stock | $0.00 | Common Stock (6216) | Indirect | ||
| Series C Preferred Stock | $0.00 | Common Stock (3271) | Indirect | ||
| Series D Preferred Stock | $0.00 | Common Stock (10395) | Indirect | ||
| Series E Preferred Stock | $0.00 | Common Stock (12998) | Indirect | ||
| Series B Preferred Stock | $0.00 | Common Stock (2927) | Indirect | ||
| Series C Preferred Stock | $0.00 | Common Stock (1539) | Indirect | ||
| Series D Preferred Stock | $0.00 | Common Stock (4895) | Indirect | ||
| Series E Preferred Stock | $0.00 | Common Stock (6120) | Indirect | ||
| Series B Preferred Stock | $0.00 | Common Stock (327556) | Indirect | ||
| Series C Preferred Stock | $0.00 | Common Stock (172421) | Indirect | ||
| Series D Preferred Stock | $0.00 | Common Stock (547941) | Indirect | ||
| Series E Preferred Stock | $0.00 | Common Stock (684970) | Indirect |
Footnotes
F1: Shares held by Versant Affiliates Fund II-A, L.P. ("VAF II-A"). Versant Ventures II, LLC ("VVC II") serves as the sole general partner of VAF II-A. Brian G. Atwood, Samuel D. Colella, Ross A. Jaffe, William J. Link, Ph.D., Donald B. Milder, Rebecca B. Robertson, Bradley J. Bolzon, Charles M. Warden, and Barbara N. Lubash are directors and/or members of VVC II and share voting and dispositive power over the shares held by VAF II-A, however, each disclaim beneficial ownership of these shares, except to the extent of their pecuniary interest in such shares. William J. Link, Ph.D. is a director of the Issuer and, accordingly, files separate Section 16 reports.
F2: Shares held by Versant Side Fund II, L.P. ("VSF II"). VVC II serves as the sole general partner of VSF II. Brian G. Atwood, Samuel D. Colella, Ross A. Jaffe, William J. Link, Ph.D., Donald B. Milder, Rebecca B. Robertson, Bradley J. Bolzon, Charles M. Warden, and Barbara N. Lubash are directors and/or members of VVC II and share voting and dispositive power over the shares held by VAF II-A, however, each disclaim beneficial ownership of these shares, except to the extent of their pecuniary interest in such shares. William J. Link, Ph.D. is a director of the Issuer and, accordingly, files separate Section 16 reports.
F3: Shares held by Versant Venture Capital II, L.P. ("VV II"). VVC II serves as the sole general partner of VV II. Brian G. Atwood, Samuel D. Colella, Ross A. Jaffe, William J. Link, Ph.D., Donald B. Milder, Rebecca B. Robertson, Bradley J. Bolzon, Charles M. Warden, and Barbara N. Lubash are directors and/or members of VVC II and share voting and dispositive power over the shares held by VAF II-A, however, each disclaim beneficial ownership of these shares, except to the extent of their pecuniary interest in such shares. William J. Link, Ph.D. is a director of the Issuer and, accordingly, files separate Section 16 reports.
F4: Each share of (i) Series B Preferred Stock will automatically convert into 1.451080982 shares of the Issuer's Common Stock, (ii) Series C Preferred Stock will automatically convert into 1.730144671 shares of the Issuer's Common Stock, (iii) Series D Preferred Stock will automatically convert into 1.879505664 shares of the Issuer's Common Stock, and (iv) Series E Preferred Stock will automatically convert into 2.692436975 shares of the Issuer's Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date.